e-VITA: European-Japanese Virtual Coach for Smart Ageing (WAVE II)
1 other identifier
interventional
240
4 countries
4
Brief Summary
The study is a multicentre Proof-of-Concept. The general objective of the e-VITA project is to develop a personalized virtual coach capable of interacting with its elderly interlocutor. The experimentation will be carried out in 4 sites: Italy, France, Germany and Japan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2023
Shorter than P25 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 18, 2023
CompletedFirst Posted
Study publicly available on registry
April 28, 2023
CompletedStudy Start
First participant enrolled
July 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2024
CompletedOctober 27, 2023
October 1, 2023
8 months
April 18, 2023
October 26, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in the Quality of Life
The EQ-5D-5L scale consists of five dimensions: mobility, independence, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, mild problems, moderate problems, severe problems and extreme problems. The participant is asked to indicate his/her health status by ticking the box corresponding to the most appropriate statement in each of the five dimensions. The numbers from the five dimensions can be combined into a 5-digit number that describes the health status of the participant.
baseline and 6 months later
Secondary Outcomes (8)
Change in usability
At 3 and 6 months from baseline
Change in frailty status
baseline and 6 months later
Change in nutritional capacity
baseline and 6 months later
Change in affinity with technology
baseline and 6 months later
Change in cognitive status
baseline and 6 months later
- +3 more secondary outcomes
Study Arms (5)
NAO robot group
EXPERIMENTALGoogle Nest Hub (2e generation) group
EXPERIMENTALGatebox group
EXPERIMENTALCelesTE robot group
EXPERIMENTALControl group
OTHERInterventions
The coaching device used is the softbank NAO 5 and NAO 6 humanoid interactive mobile robot. These robot platform allows multimodal natural language interaction and robot autonomous movement.
The coaching device used is Google Nest Hub (2e generation). This is a connected speaker enriched with a 7-chip touch screen. It has a loudspeaker and 3 microphones, making interaction possible.
The coaching device used is the Gatebox, a hologram like device which the user can interact. There are internal sensors such as a camera and a microphone allow the user to converse with the projected character. It connects to the Internet via a wireless LAN. With infrared rays and Bluetooth, it can also be connected to household appliances and other devices.
The coaching device used is the CelesTE robot, a prayer companion designed for Christian Catholic users.The intended main function of CelesTE is to be a "guardian angel", especially thought for elderly people. It can be a prayer companion, and contains a vast number of teachings, including the whole Bible. Its AI is capable of keeping a short conversation, in which the user may ask and receive an answer about a sensitive topic (such as happiness, death, faith, etc.). It can also printout a selection of contents. The coaching device CelesTE will be substituted by DarumaTO for the Japanese centers.
Participant in the control group will receive a booklet containing information and activities on well-being
Eligibility Criteria
You may qualify if:
- Able to stand and walk unaided;
- No acute or untreated medical problems;
- Montreal Cognitive Assessement test (MOCA) ≥ 22;
- Geriatric Depression Scale (GDS) \< 9;
- Short performance physical battery (SPPB) ≥ 7
- Clinical Frailty Scale score between 2 and 4.
You may not qualify if:
- Use of active implant or not-implant medical devices;
- Allergy to nichel;
- A myocardial infarction or stroke within 6 months;
- Painful arthritis, spinal stenosis, amputation, painful foot lesions or neuropathy limiting balance and mobility;
- Uncontrolled hypertension;
- Pacemaker or implantable cardioverter defibrillator;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Istituto Nazionale di Ricovero e Cura per Anzianilead
- European Unioncollaborator
Study Sites (4)
Broca Hospital
Paris, France
Diocesan Caritas Association for the Archdiocese of Cologne
Cologne, Germany
IRCCS INRCA Hospital
Ancona, 60127, Italy
Tohoku University -Smart Ageing Research Center
Miyagi, Japan
Study Officials
- STUDY DIRECTOR
Roberta Bevilacqua
IRCCS INRCA, Ancona, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 18, 2023
First Posted
April 28, 2023
Study Start
July 24, 2023
Primary Completion
March 30, 2024
Study Completion
March 30, 2024
Last Updated
October 27, 2023
Record last verified: 2023-10